蜜桃传媒app

The teaching hospital network of McGill University is an integral part of the research, teaching, and clinical activities of the Faculty of Medicine. By agreement and tradition, the administration, medical staff, and scientific personnel of these institutions are closely integrated with McGill University and form the basis for the clinical departments of the Faculty of Medicine. McGill University Health Centre (MUHC) / Centre universitaire de sant茅 McGill (CUSM) is a merger of seven teaching hospitals affiliated with the Faculty of Medicine at McGill University. The activities of the MUHC are carried out at the following locations:

• Montreal Children's Hospital, Royal Victoria Hospital, Montreal Chest Institute, and Cedars Cancer Centre at the Glen Site
• 1001 D茅carie Boulevard
• Montreal QC H4A 3J1
• Telephone: 514-934-1934
• Website:

• Montreal General Hospital
• 1650 Cedar Avenue
• Montreal QC H3G 1A4
• Telephone: 514-934-1934
• Website:

• Montreal Neurological Institute and Hospital
• 3801 University Street
• Montreal QC H3A 2B4
• Telephone: 514-398-6644
• Website:

• Lachine Hospital
• 650 16th Avenue
• Lachine QC H8S 3N5
• Telephone: 514-634-2351
• Website:

Each year, the MUHC receives close to 600,000 ambulatory visits, over 35,000 in-patient stays, performs close to 33,000 surgeries, and delivers almost 3,000 babies. In addition to its clinical expertise, the MUHC is proud of the quality and rigor of its clinical and scientific training. Together with its Research Institute, each year 1,200 research trainees; 1,159 residents, pharmacists and fellows; 1950 nursing staff; 745 medical students; and 523 technical and professional students are trained. Continuing education programs are also an integral part of delivering excellent patient care. In addition, all MUHC physicians are appointed professors at the Faculty of Medicine at McGill University.

The MUHC has close to 12,000 health care and other personnel working within the organization's seven clinical missions:

• The Montreal Children's Hospital;
• Medicine;
• Surgery;
• Neurosciences;
• Mental Health;
• Women's Health;
• Cancer Care.

The Research Institute of the McGill University Health Centre (RI-MUHC) is a world-renowned biomedical and healthcare research centre. The Institute, which is affiliated with the Faculty of Medicine of McGill University, is the research arm of the McGill University Health Centre (MUHC) 鈥� an academic health centre located in Montreal, Canada, that has a mandate to focus on complex care within its community. The RI-MUHC supports over 420 researchers and close to 1,200 research trainees devoted to a broad spectrum of fundamental, clinical, and health outcomes research at the Glen and the Montreal General Hospital sites of the MUHC. Its research facilities offer a dynamic multidisciplinary environment that fosters collaboration and leverages discovery aimed at improving the health of individual patients across their lifespan. The RI-MUHC is supported in part by the Fonds de recherche du Qu茅bec 鈥� Sant茅 (FRQS). More information is available at .

The newest addition to the MUHC is one of the most innovative academic health centres in North America. It has brought together our legacy sites鈥攖he Montreal Chest Institute, the Royal Victoria Hospital, the Montreal Children's Hospital, and a new Cancer Centre鈥攐nto one site: the Glen. At the Glen site, our vision of excellence is taking shape by integrating health care, research, and teaching on a whole new level. With custom-built facilities, state-of-the-art equipment, and nurturing healing environments, we are pushing the boundaries of innovation for our current generation and those to come. Renovations are also underway at our other MUHC sites鈥攖he Lachine Hospital, the Montreal General Hospital, and the Montreal Neurological Hospital鈥攁s we continue to strive to provide the best care for life for our patients and families. For more information on the MUHC, visit .

There are three other principal teaching hospitals:

Jewish General Hospital (Integrated Health and Social Services University Network for West-Central Montreal/Centre int茅gr茅 universitaire de sant茅 et services Sociaux (CIUSSS) du Centre-Ouest-de-l'脦le-de-Montr茅al)

• 3755 C么te Ste-Catherine Road
• Montreal QC H3T 1E2
• Telephone: 514-340-8222
• Website:

Since 1934, the Jewish General Hospital has served patients of diverse religious, linguistic, and cultural backgrounds who reside in Montreal, throughout Quebec, and beyond. As one of the province's largest acute-care hospitals, this 637-bed McGill University teaching hospital admits more than 25,000 patients per year, while handling approximately 520,000 outpatient visits, more than 86,000 emergency visits, and more than 3,900 births. The JGH is widely recognized for excellence in various specialties, including oncology at the Segal Cancer Centre, cardiology, neonatology, orthopedics, family medicine, aging, and emergency medicine in a new and significantly upgraded Emergency Department. In addition, several services鈥攊ncluding Intensive Care, Neonatal Intensive Care, Coronary Care, and the operating rooms鈥攐pened in a new critical-care pavilion in January 2016. The hospital has been designated by the government of Quebec as one of Montreal's five major service centres; as a provincial centre for high-risk obstetrical and neonatal care; and as a breast referral and investigation centre.

Treatment is provided by approximately 695 affiliated doctors, many of whom have teaching appointments at McGill University, as well as 300 medical residents per year, together with nursing and a wide range of allied health services. The Jewish General Hospital carries out more than 22% of the training for McGill's Faculty of Medicine and is home to several of the University's programs, including the McGill AIDS Centre, the McGill Centre for Translational Research in Cancer, the McGill Head and Neck Surgery and Oncology Program, and the McGill Menopause Clinic. The hospital's Lady Davis Institute is acknowledged as a world leader in many fields of research, including cancer (the Terry Fox Molecular Oncology Group), aging (the Bloomfield Centre for Studies in Aging), epidemiology (the Centre for Clinical Epidemiology and Community Studies), nursing (the Centre for Nursing Research), AIDS, cardiovascular disease, genetics, emergency medicine, nephrology, and the psychosocial aspects of illness. The outstanding quality of this work has often enabled the Lady Davis Institute to attract more funding per researcher than any other hospital-affiliated research institution in Quebec.

More information is available at .

St. Mary's Hospital Center (Montreal West Island Integrated University Health and Social Services Centre/Centre int茅gr茅 universitaire de sant茅 et services Sociaux (CIUSSS) de l'Ouest-de-l'脦le-de-Montr茅al)

• 3830 Lacombe Avenue
• Montreal QC H3T 1M5
• Telephone: 514-345-3511
• Website:

St. Mary's Hospital Center (SMHC) is an acute-care specialized McGill University affiliated teaching hospital with 271 adult beds. Its official designation as a university affiliated teaching hospital or a CHAU (Centre hospitalier affili茅 universitaire) further reinforces its commitment and ability to deliver high quality health care while playing a leading role in the areas of teaching and research. It is responsible for the training of a large cohort of undergraduate and post-graduate students in Medicine and the allied health disciplines.

Over 4,300 babies are delivered annually at St. Mary's, which is the first hospital in Montreal to have received the World Health Organization's (WHO) international recognition of Baby Friendly Hospital Status by the Quebec ministry of health. There is a progressive and active Family Medicine Centre recognized for its teaching. The Hospital also provides numerous highly specialized services such as renal dialysis, oncology, geriatric assessment, and psycho-geriatric, nuclear medicine, C.T. scanning services, as well as MRI exams. There are more than 120,000 out-patient clinic visits, 10,000 procedures through the surgical day centre, and over 11,000 patient admissions, in addition to ambulatory care visits, annually.

The Hospital is noted for its devotion to patients, motivation toward the achievement of excellence, and compassionate care. The laboratory department is the only hospital lab in the province currently certified by the College of American Pathologists since 1995. SMHC is also proud to be Canada's first hospital facility to receive the EcoLogo Program's Environmental Stewardship Award, presented to organizations in recognition of their environmentally friendly actions.

Visit the St. Mary's Hospital Center website at to learn more.

Douglas Mental Health University Institute (Montreal West Island Integrated University Health and Social Services Centre/Centre int茅gr茅 universitaire de sant茅 et services Sociaux (CIUSSS) de l'Ouest-de-l'脦le-de-Montr茅al)

• 6875 LaSalle Boulevard
• Montreal QC H4H 1R3
• Telephone: 514-761-6131
• Website:

Founded in 1881, the Douglas Mental Health University Institute has a triple mission of care, research, and teaching. A member of the McGill Integrated University Health Network (RUIS McGill) and affiliated with the World Health Organization, it offers hospitalization and extensive out-patient ultraspecialized services.

The Hospital provides child and adolescent, adult, and geriatric clinical services, and is dedicated to treating patients in the least restrictive manner possible, with a major focus on rehabilitation and successful reintegration into the community. It offers training for residents in psychiatry, as well as for medical and paramedical students from a wide range of disciplines.

The Douglas Institute is one of the largest research centres in mental health in the country, with a team of over 70 scientists and clinical researchers and around 200 university students. This team is devoted to making better sense of the causes of mental disorders-whether genetic, environmental, cultural, or social-as well as developing diagnostic tools, treatments and prevention methods. Also, the Douglas Institute Research Centre is home to McGill University centres in schizophrenia, aging, and suicide, as well as the Montreal Pan American Health Organization/World Health Organization Collaborating Centre for Reference and Training in Mental Health, which offers consultation services, research, and teaching programs here and abroad.

More information is available at .

In addition to the Teaching Hospitals listed above, the following institutions are also affiliated with McGill University and have been approved by, and have contracted with, McGill University for participation in teaching and research in one or more departments and services:

• CSSS de Gatineau (CISSS de l'Outaouais)
• 777 boulevard de la Gappe, Gatineau QC J8T 8R2

• CSSS de la Montagne (CIUSSS du Centre-Ouest-de-l鈥櫭巐e-de-Montr茅al)
• 5700 C么te-des-Neiges Road, Montreal QC H3T 2A8

• CSSS Cavendish (CIUSSS du Centre-Ouest-de-l鈥櫭巐e-de-Montr茅al)
• 5425 Bessborough Avenue, Montreal QC H4V 2S7

• Jewish Rehabilitation Hospital (CISSS de Laval)
• 3205 Place Alton Goldbloom, Laval QC H7V 1R2

• Constance-Lethbridge Rehabilitation Centre (CIUSSS du Centre-Ouest-de-l鈥櫭巐e-de-Montr茅al)
• 7005 de Maisonneuve Boulevard West, Montreal QC H4B 1T3

• MAB-Mackay Rehabilitation Centre (CIUSSS du Centre-Ouest-de-l鈥櫭巐e-de-Montr茅al)
• 7000 Sherbrooke Street West, Montreal QC H4B 1R3

• Maimonides Geriatric Centre (CIUSSS du Centre-Ouest-de-l鈥櫭巐e-de-Montr茅al)
• 5795 Caldwell Avenue, Montreal QC H4W 1W3

• Shriners Hospitals For Children
• 1003 D茅carie Boulevard, Montreal QC H4A 0A9

• Genome Building, Suite 3100
• 740 Doctor Penfield Avenue
• Montreal QC H3A 0G1
• Telephone: 514-398-8975
• Fax: 514-398-8121
• Website:

Pain research at McGill University is carried out by The Alan Edwards Centre for Research on Pain, which comprises researchers from the Faculties of Medicine, Dentistry and Science. The main goal of the Centre is to bring together the McGill community of basic and clinical pain researchers to promote research that will result in cures for chronic pain. Through its own activities and international collaborations, the Centre focuses on new discoveries and their clinical applications that will improve the prevention and treatment of chronic pain.

• McIntyre Medical Sciences Building, Room 1004
• 3655 Promenade Sir-William-Osler
• Montreal QC H3G 1Y6
• Telephone: 514-398-3512
• Fax: 514-398-7452
• Website:

This Centre concentrates on interdisciplinary research on artificial cells first invented here (Chang, McGill,1957, Science 1964) and since evolved into micro-nano systems; nanomedicine; nanobiotherapeutics; nanobiotechnology; nanotechnology; blood substitutes based on nanobiotechnology; hemoperfusion; bioencapsulation of enzymes, cells, stem cells, probiotics; regenerative medicine; delivery systems for drug, enzymes, genes, etc.

At present, the members of this centre at McGill come from different specialties: Physiology, Biomedical Engineering, Medicine, Surgery, Bioengineering, Biotechnology, and Chemical Engineering. This is an international centre with 2 international societies, which coordinates biannual meetings around the world; see . It is the editor-in-chief's office for an international journal on Artificial Cells, Nanomedicine, and Biotechnology (2017 Reuter World Ranking of 4th among 77 biomedical engineering journals) and a book series on Regenerative Medicine, Artificial Cells, and Nanomedicine. This is a public service website with complimentary reviews, papers, videos, and monographs. It is the major international reference source in this area.

• 3647 Peel Street
• Montreal QC H3A 1X1
• Telephone: 514-398-6668
• Website: www.mcgill.ca/biomedicalethicsunit

The Biomedical Ethics Unit (BEU) offers graduate courses in bioethics. These include electives for medical students, in-hospital courses, lectures, and rounds for residents and other health care workers. The BEU also administers the Master's specialization in Bioethics, which is available to students in the Faculties of Medicine, Law, Religious Studies, and the Department of Philosophy. The program emphasizes the conceptual and practical aspects of bioethics and ordinarily takes two years to complete. Current faculty members have training in philosophy, medicine, history, anthropology, sociology, epidemiology, and molecular biology. The BEU faculty and trainees are active in a variety of interdisciplinary research areas and have expertise in clinical trial methods, research ethics, genetics, reproductive technologies, access to care, public health ethics, health inequalities, biosecurity, anti-aging research, end-of-life care policies, and pharmaceutical development. We also provide in-hospital clinical ethics consultation services and serve on various Clinical and Research Ethics Committees for the McGill teaching and affiliated hospitals.

BEU members and research associates actively collaborate with faculty across McGill, as well as nationally and internationally in research, teaching, and clinical activities. There are currently five faculty members plus affiliate members, postdoctoral fellows, and graduate students.

• 740 Doctor Penfield Avenue, Room 2207
• Montreal QC H3A 0G1
• Telephone: 514-398-6028
• Fax: 514-933-8784
• Website:

The Centre for Bone and Periodontal Research was established in October 2001 to promote and facilitate research and training in the areas of bone, cartilage and periodontal disease. The Bone Centre currently represents the interests of more than 60 clinical and fundamental scientists, many of whom are recognized leaders in research pertaining to disorders such as arthritis, osteoporosis, metastatic and metabolic bone disease, and developmental disorders of the skeleton and oral cavity.

The Centre provides advanced instrumentation for hard tissue research, acts to increase the research capacity of its members and to translate advances into improved diagnosis, prevention and treatment of diseases involving the skeleton and oral cavity.

• Lady Meredith House
• 1110 Pine Avenue West, Room 205
• Montreal QC H3A 1A3
• Telephone: 514-398-4987
• Fax: 514-398-7246
• Website: www.mcgill.ca/centreformeded

The Centre for Medical Education promotes excellence and scholarship across the continuum of health sciences education. More specifically, the Centre for Medical Education at McGill:

• Encourages innovation and excellence in teaching and learning.
• Serves as a resource for curriculum development in undergraduate, postgraduate, and continuing health sciences education.
• Stimulates interest in educational research and development.
• Conducts research and scholarly work in health sciences education.
• Ensures that research advances the field of health sciences education and informs educational practice.

The Members of the Centre for Medical Education represent diverse backgrounds and disciplines and are involved in:

• Educational planning, curriculum design, and program evaluation.
• Faculty development and educational consultations.
• Research in health professions education.
• Dissemination of educational innovations and research findings.
• Mentorship of students, residents, fellows, and colleagues.

The Centre for Medical Education offers a variety of educational opportunities to students, residents, and faculty. Of interest to medical students is the Medical Education Electives Program, which is a one-month elective for those considering a career in teaching or academic medicine. For more information, visit: www.mcgill.ca/centreformeded/educational-opportunities/medical-education-electives or contact Dr. Michelle Elizov, Director of the Electives Program.

• 3640 rue de la Montagne
• Montreal QC H3G 2A8
• Telephone: 514-398-6962
• Fax: 514-398-8123
• Website:

The Centre for Research on Brain, Language and Music (CRBLM) at McGill University is a Regroupement Strat茅gique whose mission is to promote research and training in the areas of language and music neuroscience, performance, and development. Participating universities include McGill, Universit茅 de Montr茅al, UQAM, and Concordia. Our infrastructure for language and music research is unparalleled, including research facilities located in the McGill Faculties of Medicine, Science, Arts, and Education, as well as the International Laboratory for Brain and Music Research (BRAMS) located at the Universit茅 de Montr茅al. Our specific objectives include:

1. promoting the scientific study of language and music neuroscience, performance, and development;
2. stimulating interdisciplinary and cross-domain collaboration among researchers on basic and applied problems in language and music;
3. fostering innovative research training for graduate and postdoctoral students;
4. disseminating research findings to clinical and educational end-users;
5. forming national and international partnerships.

Our goal is to develop a fundamental theoretical, behavioral, and neuroscientific understanding of the neurobiological, social, and communicative processes of language and music.

• McIntyre Medical Sciences Building, Room 1324
• 3655 Promenade Sir-William-Osler
• Montreal QC H3G 1Y6
• Telephone: 514-207-9887
• Fax: 514-398-2045
• Website: www.mcgill.ca/crrd

The Centre for Research in Reproduction and Development (CRRD), originally established as the Centre for the Study of Reproduction in 1982, is among the longest-standing research centres at McGill and was a founding partner of the FQRNT-funded R茅seau Qu茅becois en Reproduction (RQR). Today, the interdepartmental and interdisciplinary CRRD is home to more than 30 principal investigators, 60 graduate students, 40 fellows and research associates, and 20 technical support staff from 11 departments, 3 faculties, and 8 divisions at the University. With such critical mass, the CRRD has established itself as one of the most productive and dynamic research hubs for young and established researchers committed to the science of reproduction and development.

The research programs of our members span a wide range of diverse and complementary topics, including understanding the basic biological mechanisms that control developing eggs and sperm within the gonads, how the reproductive hormones are produced and exert their effects, how the developing embryo implants into the uterus and establishes communication with its mother, causes and cures for conditions such as pre-eclampsia and intra-uterine growth retardation, and the effects of environmental pollutants and disease on the development of the eggs and sperm and of the fetus. We use both animal model systems and human clinical studies to reach our research objectives.

The CRRD enables and promotes interactions between investigators at McGill, other universities in Quebec, across Canada, and internationally.

• Lady Davis Institute for Medical Research
• Jewish General Hospital
• 3755 C么te Ste-Catherine
• Montreal QC H3T 1E2
• Telephone: 514-340-8222 ext. 28873
• Website: www.mcgill.ca/translational-research-cancer

The aim of the Centre is to facilitate the translation of the exciting novel findings made in fundamental laboratories into testable hypotheses for evaluation in clinical trials in oncology. There are currently extremely high quality clinical research activities at McGill, and the fundamental investigations of cancer biology by McGill scientists are recognized worldwide. The Centre provides the infrastructure to bring these investigators together in order to synergize their efforts at generating novel and promising translational research. This provides a structured focus for these activities and will accelerate the testing of potential benefits derived from scientific discovery.

The Centre provides core functions to enhance translational research, including a Molecular Pathology Centre with a centralized biobank, a Clinical Research Unit with extensive experience in novel therapeutics testing, a Proteomics Facility with a proteogenomics platform, and a Molecular Modeling Program. The unique interaction of clinician-scientists and Ph.D. researchers provides an important strength to novel therapeutic development programs. There is significant interaction with biotechnology and the pharmaceutical industry.

The Centre provides a high quality environment for training clinician-scientists in cancer research. The trainees include both graduate students (Experimental Medicine, Pharmacology and Therapeutics, Pathology) as well as Ph.D. and M.D. scientists interested in postdoctoral experience working specifically on clinically oriented or relevant models or problems.

• Email: info [at] ludmercentre.ca
• Website:

The Ludmer Centre for Neuroinformatics & Mental Health was founded on the belief that science is on the cusp of a revolution in our ability to understand and treat brain disorders, provided we can bring together the right computational infrastructure, datasets, and expertise to apply a big-data approach to brain research.

An innovative partnership between three cutting-edge McGill-affiliated research facilities, the Centre brings together four complementary research pillars鈥攏euroinformatics, neuroimaging, epigenetics, and statistical genetics鈥攗nder the scientific leadership of three world-renowned leaders supported by a cadre of over 75 researchers and neuroinformatics staff. Together, they lead innovative research that is generating novel datasets and insights, while concurrently innovating and expanding the "big-data" tools and computational infrastructure required for their analysis.

• Dr. Michael Meaney leads the Centre鈥檚 epigenetics pillar, the Sackler Program for Epigenetics & Psychobiology at the Douglas Mental Health University Institute Research Centre.
• Dr. Alan Evans leads the neuroimaging and neuroinformatics pillars, the McGill Centre for Integrative Neuroscience (MCIN) at the Montreal Neurological Institute.
• Dr. Celia Greenwood leads the statistical genetics pillar, the Genomics, Bioinformatics & Statistical Genetics lab at the Lady Davis Institute for Medical Research at the Jewish General Hospital.

A key Ludmer Centre goal is the mentorship of new researchers across varied disciplines鈥攖o develop transdisciplinary research cadres capable of maximizing the potentials inherent in the Centre鈥檚 neuroinformatics infrastructure, tools, and datasets. Supported by a team of informatics experts, graduate, master's, and doctoral students are offered unique hands-on opportunities to advance mental health and neurodegenerative research while contributing to the expansion of Canada鈥檚 leading neuroinformatics infrastructure.

To learn more, to join our mailing list.

Based at the Lady Davis Institute for Medical Research at the Jewish General Hospital

• 3755 C么te Ste-Catherine, Room F-318
• Montreal QC H3T 1E2
• Telephone: 514-340-7536
• Fax: 514-340-7537
• Website:

The McGill AIDS Centre was founded at the Lady Davis Institute, Jewish General Hospital, to coordinate, facilitate, and promote teaching, research, and treatment activities relating to HIV infection and AIDS. It has made McGill University one of the preeminent institutions of its kind in Canada. Led by founding director, Dr. Mark A. Wainberg, the McGill AIDS Centre has made significant contributions since the outbreak of the AIDS pandemic in 1981, helping to transform HIV from a deadly infection to a manageable chronic disease.

The Centre believes in a multidisciplinary approach, and has been the home of a large group of talented McGill researchers who have been working on HIV from diverse aspects with the goal of furthering prevention and treatment options. We are proud of the many groundbreaking discoveries that we have made in understanding the basic biology of HIV infection, elucidating host immune responses to control HIV infection, discovering the transmission of drug-resistant HIV in human populations, and characterizing the development of drug resistance to HIV, to name just a few examples of the initiatives that have earned the McGill AIDS Centre a national and international reputation. In particular, Dr. Wainberg became an icon in the International AIDS Society (IAS). As President of the IAS from 1998 to 2000, he was responsible for holding the 2000 IAS meeting in Durban, South Africa, a milestone event in the international fight against AIDS. He chaired the 2006 IAS meeting in Toronto. Dr. Wainberg鈥檚 lab discovered the anti-HIV-1 activity of 3TC in the early 1990s and, recently, demonstrated the superior anti-HIV-1 activity of Dolutegravir. Both of these drugs are now used in first line antiretroviral regimens.

McGill AIDS Centre scientists have played an important role in developing countries where HIV is endemic, collaborating with local scientists and health authorities to help stave off the spread of the infection. Our scientists have played lead roles in articulating a need for access to antiretroviral drugs for all in need, regardless of where they live or their ability to pay.

Over the past three decades, the McGill AIDS Centre has built a strong team of excellent researchers and clinicians who have broad expertise in basic virology, immunology, drug discovery, epidemiology, population studies, and clinical research. Based at the Lady Davis Institute are the level 3 biocontainment facility, genotyping platform and other state-of-the-art research equipment that can be readily employed to study other emerging and re-emerging pathogenic human viruses.

Educational and training activities will be augmented to ensure there is sufficient manpower for the growing HIV epidemic. The care and treatment of persons who are infected with HIV or who have developed AIDS will be enhanced through coordination across the McGill network of hospitals and clinics. Furthermore, the Centre will provide a forum for the input and participation of patients with HIV infection or AIDS in all aspects of research, teaching, and care.

In honor of Dr. Mark Wainberg, for his dedication to HIV research, his tireless advocacy for the rights and benefits of HIV patients, and his vision to go beyond HIV to combat other important emerging pathogenic human viruses, the McGill AIDS Centre will be renamed the 鈥淲ainberg Centre for Complex and Emerging Viral Infections.鈥� More details will follow.

• Montreal General Hospital, Livingston Hall, L7 128
• Research Institute of the McGill University Health Centre
• 1650 Cedar Avenue
• Montreal QC H3G 1A4
• Telephone: 514-934-8094
• Fax: 514-934-8216
• Website: www.mcgill.ca/crn

The McGill Centre for Research in Neuroscience (CRN), which was officially established as a University Centre in 1986 under the leadership of Dr. Albert Aguayo, is a vibrant research centre that brings together basic and clinical scientists in highly interactive research groups.

With construction of new CRN laboratories in 1993 and continued expansion since, the group has broadened its focus to include research into the development of neural tissues, synapse formation and plasticity, the assembly and function of neural circuits, and behavior, while maintaining its strengths in regeneration and repair.

The CRN has been and remains home to some of Canada鈥檚 most distinguished neuroscientists. We number more than 60 trainees and staff at any time, including postdoctoral researchers, graduate students, undergraduates, and technicians. The CRN offers a program to train pre-doctoral students for an M.Sc. or Ph.D. degree, as well as postdoctoral Ph.D. or M.D. graduates for careers in biomedical research.

• Research Institute of the McGill University Health Centre
• 1001 boulevard D茅carie, Glen Block E
• Program Mail Drop EM3 3211
• Montreal QC H4A 3J1
• Telephone: 514-934-1934, ext. 42815
• Website: www.mcgill.ca/tb

The McGill International TB Centre brings together over 20 investigators with expertise spanning epidemiology, socio-behavioural, and economic analyses of TB, to microbiology to host genetics and immune response. The work is done both at an academic centre and with a number of collaborating groups around the world. Please consult www.mcgill.ca/tb where we introduce the faculty members who are members of our centre and describe our training programs for students. Find out why our Centre is a world leader in the interdisciplinary study of TB and how we work together to unravel the many mysteries of this recalcitrant disease.

• 6825 boulevard LaSalle
• Verdun QC H4H 1R3
• Telephone: 514-766-2010
• Website:

The McGill University Research Centre for Studies in Aging (MCSA) is committed to investigating causes and possible treatments of the dementias, especially Alzheimer's disease. During the past decades, the MCSA has played a pioneering role in identifying genetic abnormalities leading to an increased risk for Alzheimer's disease. The Memory Clinic of the Alzheimer's Disease Research Unit, under the leadership of Dr. Serge Gauthier, is focusing on improved therapies, long-term treatment of subjects affected by dementia, and enhancing the quality of life of patients and caregivers. Over the last 30 years the priority of the MCSA evolved to primary prevention of cognitive decline, early diagnosis, and treatment for persons with mild or prodromal symptoms, and best treatments for patients with various types of dementia. The importance of genes such as ApoE as risk factors and as predictors of response to treatment in Alzheimer鈥檚 disease was one of the significant contributions of the MCSA to the field of aging. Another achievement of the MCSA is the strong link with academic research centres around the world, including Brazil, China, and Germany, which is reflected by a steady flow of students and visiting scholars from these countries among others.

In Canada, the MCSA created the academic trial network C5R and has hosted consensus meetings on the best evidence-based approach to the diagnosis and management of various types of dementia. The current focus of the MCSA is on prevention, and the development of tools and methods to allow earliest diagnosis and intervention of age-related disease. Prevention has been identified as an important objective in dementia research by national and international institutes (Alzheimer Society of Canada, National Institute of Aging USA) and is a priority of McGill University over the next decade. The MCSA contributes to this effort with its Dementia Prevention Program that was launched in 2012, entitled 鈥淧revention of Neurodegenerative Disease in Everyone at Risk鈥� (P.O.N.D.E.R.). This program, in close cooperation with the Douglas Institute and other research centres in Quebec, was established with three goals: (a) provide a free platform for adults aged 40鈥�90 to engage in cognitive training; (b) determine normative cognitive performance in middle-to-old adulthood, and (c) identify persons showing early signs of cognitive impairment that are at risk of developing late-onset dementia. This will allow the tracking and documentation of changes in the structural and functional integrity of the human brain in normal and pathological aging, while providing researchers with important data about possible predictors of dementia. Presently, the P.O.N.D.E.R. software is being upgraded.

The MCSA has established a computational infrastructure devoted for teaching neuroimaging in dementia for fellows, graduate, and postdoctoral students. This infrastructure program is under the direction of Dr. Pedro Rosa-Neto, M.D., Ph.D. The Translational Neuroimaging Laboratory at the MCSA aims to understand how toxic proteins cause brain damage in Alzheimer鈥檚 disease patients. We also develop novel methodologies for early detection of these toxic proteins in the persons without symptoms (see the ). Research in the field of neuroimaging has been focusing on the early detection of dementia, and AD prevention. Our clinic collaborates with other experts at McGill University using the most advanced and sensitive Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) protocols to evaluate patients with mild cognitive complaints. The PET and MRI technologies, combined with our clinical expertise, allow for early diagnosis and appropriate treatment of the condition causing memory deficits.

Recent research advancements: Scientific Software Engineer of MCSA, Sulantha Mathotaarachchi, develops artificial intelligence models to predict the progression of dementia using various biomarker measurements, such as MRI, PET, CSF and neuropsychological assessments: Article 鈥淚dentifying incipient dementia individuals using machine learning and amyloid imaging,鈥� by S. Mathotaarachchi supervised by MCSA Director, Dr. Pedro Rosa-Neto and Dr. Serge Gauthier. Their findings appear in a new study published in the journal . This research was funded by the Canadian Consortium on Neurodegeneration in Aging (CCNA) and the Canadian Institutes of Health Research (CIHR). The above research findings were announced in high impact international press such as: Newsweek (USA), NBC News, McGill Reporter, and Le Devoir.

• 1160 Pine Avenue West
• Montreal QC H3A 1A3
• Telephone: 514-398-3535
• Fax: 514-398-6769
• Website:

The mission of the Rosalind and Morris Goodman Cancer Research Centre is to bring together internationally renowned scientists who are devoted to cancer research and provide them with state-of-the-art resources so that they can fully contribute to the worldwide effort of developing novel approaches for the improvement of the diagnosis, treatment, and management of this disease. Investigators within the Cancer Centre have made significant contributions toward the molecular understanding of diseases such as cancer which can be exploited to better stratify cancer and facilitate the development of novel therapeutic approaches.

The Goodman Cancer Research Centre provides an internationally recognized training ground for the next generation of investigators who will pursue research in the life sciences and cancer. The Centre plays a key role in reaching out and educating the public on the fundamentals of cancer research and understanding the causes of cancer, its prognosis, and its treatment.

Further information is available at Rosalind and Morris Goodman Cancer Research Centre.